Question 1 · Medium
A 54-year-old man has had type 2 diabetes for 8 years and takes metformin 1 g twice daily; HbA1c is 8.1%. Last month he was admitted with heart failure, and echocardiography shows an ejection fraction of 32%. eGFR is 58 mL/min/1.73 m². Which drug is the best to add?
- ASaxagliptin
- BPioglitazone
- CGlibenclamide
- DDapagliflozin
Show answerHide answer
Answer: D · Dapagliflozin
SGLT2 inhibitors lower glucose by blocking proximal tubular glucose reabsorption, and in large trials they reduced heart-failure hospitalisation and cardiovascular death and slowed CKD, even in people without diabetes. Current diabetes guidance therefore recommends an SGLT2 inhibitor for anyone with heart failure or CKD, whatever the HbA1c. His eGFR is high enough to start one. Counsel him about genital mycotic infection and euglycaemic ketoacidosis, and to stop the drug during acute illness or before surgery.
- A: Saxagliptin increased heart-failure admissions in its outcome trial.
- B: Pioglitazone causes fluid retention and is contraindicated in heart failure.
- C: Sulfonylureas cause hypoglycaemia and weight gain and give no heart-failure benefit.